Recombinant human GLP-1 (24 nmol/kg/d) reduced hyperglycemia in streptozotocin (STZ)-induced diabetic mice, and superoxide dismutase and glutathione peroxidase activities were enhanced in the pancreas [103]. Here, GLP1R is linked to Hyperglycemia.